variants of concern – Page 15 – Communicable Diseases Research

Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity

Article

Published on 2022-10-262022-11-15
Journal: mBio [Category] COVID19(2023년), SARS, 변종, 진단,

Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant

Article

Published on 2022-10-262022-11-15
Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 치료기술,

[키워드] Abbott Affect Analysis analyzed Antigen carried Characteristics Clinical characteristics clinical information collected COVID-19 Decreased Delta delta variant Diagnosis diagnostic diagnostics Effectiveness Epidemic evaluate explained Factor Health care worker individual Infection International less load Lower marker median Mutation nasopharyngeal specimen National omicron PanBio performed positive question Rapid Rapid diagnostic test RDT RDTs reduced repeated replicate RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant screening strategy sensitivity shown significantly higher significantly lower specific mutation Test the disease Variability variant variants variants of concern Viral load viral replication Virological VoC
[DOI] 10.1128/spectrum.01922-22 PMC 바로가기

Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike

Article

Published on 2022-10-262022-11-15
Journal: Journal of Virology [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] acid acute respiratory syndrome addition addressed Amino acid amino acid substitution antigenic Antisera Care caused characterized coronavirus COVID-19 death demonstrated expressing expression level fitness FIVE GISAID globe greater Health highlight host immunity identifying Immune escape immune evasion immunological profile initiative Intervention L452 less lineages maintain mutant Mutation mutational studies Naturally neutralization pandemic phenotypic position promote pseudovirus retrieved SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 variant selected sensitivity sequence single nucleotide spike Spike protein Substitution T cell Transmissibility variants of concern viral evolution viral fitness viral infectivity virus VoC
[DOI] 10.1128/jvi.01162-22 PMC 바로가기

Genomic Epidemiology and Serology Associated with a SARS-CoV-2 R.1 Variant Outbreak in New Jersey

Article

Published on 2022-10-262022-11-15
Journal: mBio [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, 치료기술,

[키워드] acute respiratory syndrome antibody antibody resistance attack rate B.1.351 B.1.526 Care caused characteristic Clinical use collected Community Complete coronavirus COVID-19 Critical E484K mutation Evidence Examining exhibit exhibited hcp Health highlight individual infected individuals Infection Inpatient Lineage loss of activity monoclonal antibody Mutation N-terminal domain neutralization capacity Neutralizing antibody response neutralizing capacity New nosocomial NTD outbreak P.1 Patient plasma positive professional professionals proportion pseudovirus psychiatric facility Receptor binding domain reported reverse transcription robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant sera Spike protein Symptom symptomatic COVID-19 disease tested the SARS-CoV-2 the United State treat vaccinated individual vaccinated individuals vaccination Vaccine variant variants of concern VOCs wild type
[DOI] 10.1128/mbio.02141-22 PMC 바로가기

Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern

Article

Published on 2022-10-262022-11-15
Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, 치료제,

[키워드] acute respiratory syndrome approach collected concern coronavirus COVID-19 COVID-19 pandemic Critical cross-reactivity Delta delta variant detect different time points equipment exhibited FIVE genotyping identify Laboratory lack Limits of detection management melting curve analysis Molecular assay multiplex Multiplex PCR Mutation mutations nine omicron Omicron variant other coronaviruses PCR PCR assay performed platform positive sample Rapid rapid genotyping. Real-time PCR resource RNA SARS-CoV-2 SARS-CoV-2 VOCs selected sensitivity Sequencing signature specificity Spike protein Support Surveillance variant variants variants of concern VoC VOCs WGS
[DOI] 10.1128/spectrum.03222-22 PMC 바로가기

A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses

Article

Published on 2022-10-252022-11-15
Journal: Cell Reports [Category] COVID19(2023년), SARS, 변종, 진단,

Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins

Article

Published on 2022-10-242022-11-16
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종,

Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human

Article

Published on 2022-10-212022-11-16
Journal: Frontiers in Immunology [Category] 변종, 유전자 메커니즘,

[키워드] analyzed antibody approach booster booster dose caused correlation COVID-19 differentially expressed gene dose effective Effectiveness Efficacy Factor Health help Heterologous homologous humoral humoral immune response Humoral immunity immune Immune escape immune response Immunity immunization inactivated Inactivated vaccine indicated innate immune function innate immune pathways participant Perspective Prevalence protein subunit vaccine provided significantly Support System third booster vaccine transcriptional response Transcriptome transcriptome analysis transcriptomic analysis vaccination Vaccine variants of concern VOCs with COVID-19
[DOI] 10.3389/fimmu.2022.1027180 PMC 바로가기

Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants

Article

Published on 2022-10-202022-11-15
Journal: Viruses [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단,

Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses’ Vaccinated Solid Organ Transplant Recipients

Article

Published on 2022-10-192022-11-15
Journal: Viruses [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] administration analyzed booster booster dose booster doses Breakthrough infection cellular response CLIA Cohort COVID-19 dose Efficacy ELISA ELISpot assay fourth dose General population humoral IgA IgA level IgG immune immune response IMPROVE in both group Infection mRNA mRNA vaccine natural natural infection new SARS-CoV-2 no difference Organ transplant Patient positive recipient recipients repeated response SARS-CoV-2 SARS-COV-2 infection secretion serum IgG severe COVID-19 significant increase significantly increased Solid solid organ transplant Solid organ transplant recipients Still T cell T-cell T-cell Response Transplant vaccination Vaccine vaccine-induced immune response variants of concern
[DOI] 10.3390/v14102299 PMC 바로가기